Compare NUVB & WB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | NUVB | WB |
|---|---|---|
| Founded | 2018 | 2009 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.9B | 2.5B |
| IPO Year | N/A | 2014 |
| Metric | NUVB | WB |
|---|---|---|
| Price | $8.98 | $10.20 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 8 | 1 |
| Target Price | $10.63 | ★ $14.00 |
| AVG Volume (30 Days) | ★ 6.1M | 873.3K |
| Earning Date | 11-03-2025 | 11-18-2025 |
| Dividend Yield | N/A | ★ 16.16% |
| EPS Growth | N/A | ★ 20.16 |
| EPS | N/A | ★ 1.76 |
| Revenue | $26,748,000.00 | ★ $1,740,785,000.00 |
| Revenue This Year | $609.55 | $0.53 |
| Revenue Next Year | $197.91 | $2.38 |
| P/E Ratio | ★ N/A | $5.78 |
| Revenue Growth | ★ 1137.19 | N/A |
| 52 Week Low | $1.54 | $7.10 |
| 52 Week High | $9.75 | $12.96 |
| Indicator | NUVB | WB |
|---|---|---|
| Relative Strength Index (RSI) | 61.71 | 49.09 |
| Support Level | $8.84 | $10.00 |
| Resistance Level | $9.75 | $10.29 |
| Average True Range (ATR) | 0.43 | 0.17 |
| MACD | -0.11 | 0.03 |
| Stochastic Oscillator | 56.50 | 56.82 |
Nuvation Bio Inc is a biopharmaceutical company tackling unmet needs in oncology by developing differentiated and novel therapeutic candidates. Its product candidate, taletrectinib, is an oral, potent, central nervous system-active, selective, next-generation c-ros oncogene 1 (ROS1) inhibitor specifically designed for the treatment of patients with ROS1+ non-small cell lung cancer (NSCLC). In addition, its clinical-stage pipeline includes differentiated, novel oncology product candidates such as Safusidenib, NUV-1511, and NUV-868 in their different stages of development. The company generates revenue through out-licensing collaborative agreements with its customers located in China and Japan.
Weibo Corp is a China-based company mainly engaged in the social media advertising business for people to create, discover and distribute content. The company's activities include Advertising and Marketing, which mainly provides a full range of advertising customization and marketing solutions. The Value-added Services mainly provide services such as membership services on social platforms, online games, live broadcasts, social e-commerce, and others. The Company's main product is the social platform Weibo.